Insider Buying: Cosmos Health (NASDAQ:COSM) CEO Purchases 218,447 Shares of Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 218,447 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The shares were acquired at an average cost of $0.21 per share, for a total transaction of $45,873.87. Following the purchase, the chief executive officer owned 13,481,808 shares of the company’s stock, valued at $2,831,179.68. This represents a 1.65% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, June 10th, Grigorios Siokas purchased 701,447 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.23 per share, for a total transaction of $161,332.81.

Cosmos Health Price Performance

Cosmos Health stock traded up $0.00 during mid-day trading on Friday, reaching $0.21. 4,182,989 shares of the company’s stock traded hands, compared to its average volume of 1,232,909. Cosmos Health Inc. has a 12-month low of $0.20 and a 12-month high of $1.32. The company has a quick ratio of 0.92, a current ratio of 1.08 and a debt-to-equity ratio of 0.31. The stock has a 50 day moving average of $0.31 and a two-hundred day moving average of $0.40. The company has a market cap of $12.91 million, a price-to-earnings ratio of -0.32 and a beta of 4.79.

Cosmos Health (NASDAQ:COSM) last issued its quarterly earnings data on Thursday, May 21st. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.06). Cosmos Health had a negative return on equity of 52.85% and a negative net margin of 30.41%.The business had revenue of $18.40 million for the quarter, compared to the consensus estimate of $17.93 million. Equities analysts forecast that Cosmos Health Inc. will post -0.06 earnings per share for the current year.

Institutional Investors Weigh In On Cosmos Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Renaissance Technologies LLC increased its position in Cosmos Health by 16.7% during the 1st quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock valued at $124,000 after purchasing an additional 55,925 shares during the period. Citadel Advisors LLC increased its holdings in shares of Cosmos Health by 133.1% in the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after acquiring an additional 128,776 shares during the period. Finally, XTX Topco Ltd increased its holdings in shares of Cosmos Health by 52.1% in the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after acquiring an additional 34,117 shares during the period. 12.61% of the stock is currently owned by hedge funds and other institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.